Doan Y Dao, M.D., is a co-founder and the past President the Vietnam Viral Hepatitis Alliance (V-VHA).

He is currently a Transplant Hepatology Fellow at Massachusetts General Hospital and will be joining the institution as a general and transplant hepatologist, with a faculty appointment at Harvard Medical School (07/2026).

Dr. Dao cares for patients with chronic liver disease and has a research focus on hepatitis B virus (HBV) and hepatocellular carcinoma (HCC), including biomarker development for early detection and chemoprevention strategies.

His work spans clinical care, translational research, and global health, with ongoing collaborations in the United States, Vietnam, and Saudi Arabia. He has contributed to viral hepatitis programs in Vietnam focused on screening, linkage to care, and research capacity building.

Dr. Dao has been involved in HBV research and patient care for over a decade, with experience in clinical research, translational science, and public health implementation. His long-term goal is to advance scalable solutions for HBV and liver cancer in high-burden settings.

Born and raised in Vietnam, Dr. Dao is fluent in English and Vietnamese and remains committed to improving outcomes for patients affected by HBV globally.